Quick Summary
Covering the latest research from top Wall Street investment banks

MSCI China 2Q26 earnings were broadly in line with expectations and improved from 1Q26, but A-share breadth and overall revenue remained weak

Institution
Morgan Stanley
Date
20260826
Authors
Chloe Liu, Laura Wang, Vicky Wu, Jonathan F Garner
Company
Ticker
Industry
Multi-industry/Asset Allocation
Rating
MixedMedium confidenceShort-termThe report believes MSCI China's interim 2Q26 earnings were broadly in line with expectations and improved from 1Q26, but A-share earnings surprise breadth remained weak, while revenue performance in both markets also lagged earnings performance.
AuthorsChloe Liu, Laura Wang, Vicky Wu, Jonathan F Garner
CoverageChina
Research firm divisions/subsidiariesChina Equity Strategy | Asia Pacific(Division/Team)、MORGAN STANLEY ASIA LIMITED(Subsidiary/Legal Entity)、MORGAN STANLEY ASIA (SINGAPORE) PTE.(Subsidiary/Legal Entity)

AI summary card

MSCI China 2Q26 earnings were broadly in line with expectations and improved from 1Q26, but A-share breadth and overall revenue remained weak

Morgan Stanley's interim review shows that market-cap-weighted earnings for both MSCI China and A-shares were broadly in line with expectations, but A-share performance measured by company count still fell short of expectations. Revenue was generally weaker than earnings, indicating that cost control and operating efficiency remained important supports for results.

China Equities2Q26 ResultsMSCI ChinaA-sharesEarnings BeatWeak RevenueHealth CareInformation TechnologyArtificial IntelligenceConsumption
  • MSCI China's net earnings beat measured by company count was +4.3%, while its market-cap-weighted beat was +3.7%, both improving from 1Q26.
  • A-shares recorded a net earnings miss of -5.7% measured by company count, but a market-cap-weighted beat of +2.7%.
  • MSCI China's health care and information technology sectors delivered earnings beats under both measures.
  • MSCI China nonfinancial revenue recorded a net miss of -9.9% measured by company count and 0.0% on a market-cap-weighted basis.
  • A-share nonfinancial revenue missed expectations by -14.8% measured by company count and by -0.4% on a market-cap-weighted basis.
  • The divergence of earnings outperforming revenue continued, with the report attributing support to cost control and operating efficiency.

Report interpretation

Overview

The report provides an interim review of China's 2Q26 earnings season, separately examining MSCI China and the A-share market represented by the MSCI China A Onshore Index. The core conclusion is that MSCI China earnings were broadly in line with expectations and improved from 1Q26, while market-cap-weighted A-share earnings were also broadly in line, but A-share breadth measured by company count was weaker; revenue performance in both markets lagged earnings.

Core views

This review covers results reported through August 21, 2026, and remains an interim observation of the earnings season. A total of 191 MSCI China constituents had reported 2Q26 results, and the earnings surprise analysis used 140 companies with reasonable-quality consensus data, representing 24% of the index's company count and 42% of its weight. Measured by company count, MSCI China's net earnings beat was +4.3%, a notable improvement from -8.7% in 1Q26; on a market-cap-weighted basis, the earnings beat was +3.7%, also better than -3.0% in 1Q26. Morgan Stanley therefore judges that current earnings performance is broadly in line with expectations and that the trend has improved, while emphasizing that it remains to be seen whether this performance can be sustained through the full earnings season. MSCI China's sector performance showed clear divergence. Of the 11 sectors, four currently recorded net beats measured by company count. Among sectors where companies representing more than 30% of sector market capitalization had reported, health care and information technology both delivered earnings beats on company-count and market-cap-weighted measures. With 48% of sector market capitalization reported, health care posted a +29.4% net beat measured by company count and a +15.5% market-cap-weighted beat, with major contributors including WuXi AppTec and Sino Biopharmaceutical. With 38% reported, information technology posted +9.4% and +8.5%, respectively, with major contributors including Lenovo and GDS Holdings. Consumer discretionary recorded a net miss on a company-count basis. Results from internet companies Tencent, Alibaba, and JD.com were broadly in line with expectations, while losses in food delivery continued to narrow, consistent with the report's prior assessment. Looking toward subsequent quarters, rising artificial intelligence investment and weak consumption remain key variables in investor discussions. Revenue was weaker than earnings. The MSCI China revenue analysis excluded financials and selected 121 of the 175 companies that had reported and had reasonable-quality consensus data, covering 25% of the index's company count and 37% of its weight. Measured by company count, revenue recorded a net miss of -9.9%, while the market-cap-weighted result was 0.0%, meaning revenue at large index heavyweights was generally in line with expectations while the broader set of companies performed weakly. Of the 10 sectors, only one recorded a net beat measured by company count. Among sectors with at least 30% of market capitalization reported, health care was the only sector to beat revenue expectations under both measures, while consumer staples missed under both. The report believes earnings outperforming revenue indicates that cost control and operating efficiency supported profits rather than performance relying entirely on revenue growth. For A-shares, the report uses constituents of the MSCI China A Onshore Index as a proxy for the A-share universe. As of August 21, 2026, 172 companies had reported 2Q26 earnings; the analytical sample comprised 106 companies with reasonable-quality consensus data, representing 19% of the index's company count and 32% of its weight. A-share earnings recorded a net miss of -5.7% measured by company count, although this improved from -12.5% in 1Q26; the market-cap-weighted beat was +2.7%, above +0.3% in 1Q26, so the weighted result was still regarded as broadly in line with expectations. Currently, only two of the 11 sectors recorded net beats measured by company count. With 47% of sector market capitalization reported, communication services beat expectations on both company-count and market-cap-weighted measures, with Beijing Kunlun Tech among the major contributors. With 39% reported, information technology beat expectations measured by company count and was in line on a market-cap-weighted basis. With 59% reported, consumer staples recorded a market-cap-weighted earnings miss, with Angel Yeast among the major detractors. A-share revenue breadth further indicates that fundamentals remain weak. Among the 171 companies that had reported, the revenue analysis selected 81 nonfinancial companies, representing 16% of the index's company count and 23% of its weight. Measured by company count, revenue recorded a net miss of -14.8%, although the magnitude of the miss improved slightly from 1Q26; the market-cap-weighted result was -0.4%, which the report still regarded as broadly in line with expectations. Among sectors with at least 30% of market capitalization reported, no sector simultaneously delivered a revenue beat, while consumer staples missed on both company-count and market-cap-weighted measures. This shows that results at large A-share index heavyweights were better than overall company breadth, but revenue has yet to show broad-based improvement. In addition to current earnings surprises, the report also presents long-term trends in earnings revision breadth and 12-month P/E ratios for MSCI China overall and for sectors including energy, materials, capital goods, technology hardware, media and entertainment, automobiles, health care, pharmaceuticals, banks, insurance, transportation, consumer durables, telecommunications, utilities, retail, and real estate. These are shown side by side to assess changes in earnings expectations and valuation trends; the input does not provide specific numerical conclusions corresponding to these charts.

Analysis framework

The report first limits the sample to companies that had reported results as of August 21, 2026 and had reasonable-quality consensus data, then compares actual results with market consensus using two measures: net surprise breadth calculated by company count and market-cap-weighted surprise. It then breaks down the analysis across MSCI China versus A-shares, earnings versus revenue, and the overall index versus sectors, while comparing the results with 1Q26. Finally, it examines changes in expectations and valuation trends through long-term charts of earnings revision breadth and 12-month P/E ratios.

Methodology notes

  • Quantitative/Factor/Portfolio Theory

    Dual measures of earnings surprises by company count and market-cap weighting

    The net surprise measured by company count is used to assess whether earnings improvement is broad-based, while the market-cap-weighted surprise reflects the influence of larger index constituents. The report uses both measures to identify differences between overall company performance and index-weighted performance.

  • Quantitative/Factor/Portfolio Theory

    Index constituent proxy and consensus data screening

    The report analyzes MSCI China constituents to assess Chinese offshore and overall equity performance, while using MSCI China A Onshore Index constituents as a proxy for the A-share universe; only companies that had reported and had reasonable-quality consensus data were included in the surprise calculations.

  • Corporate Fundamentals and Financial FrameworkEarnings Quality Analysis

    Analysis of divergence between earnings and revenue surprises

    The report compares profit-side and revenue-side performance relative to consensus expectations. Revenue being weaker than earnings while earnings remain broadly in line with expectations implies that cost control and operating efficiency are important supports for current profit performance.

  • Cycle and Business Conditions Framework

    Comparison of earnings revision breadth (ERB) with 12-month P/E trends

    The report presents changes in the breadth of upward and downward earnings revisions alongside 12-month P/E trends to assess the long-term relationship between changes in earnings expectations and valuations, but the input does not provide specific numerical conclusions from the charts.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

  • MSCI China
    Interim 2Q26 earnings were broadly in line with consensus expectations and improved from 1Q26, but revenue breadth remained weak.
    Strengths
    Market-cap-weighted earnings beat of +3.7%; health care and information technology delivered earnings beats under both measures.
    Weaknesses
    Nonfinancial revenue recorded a net miss of -9.9% measured by company count, and only one sector delivered a net revenue beat on a company-count basis.
    Comparison
    Earnings performance improved from 1Q26 and was generally better than revenue performance.
    Risks
    The current earnings analysis covers only 42% of the index weight, and it remains to be seen whether the trend can be sustained through the end of the earnings season.
  • A-share market represented by the MSCI China A Onshore Index
    Market-cap-weighted earnings were broadly in line with expectations, but earnings and revenue measured by company count both missed expectations.
    Strengths
    Market-cap-weighted earnings beat of +2.7%, above +0.3% in 1Q26; communication services and information technology led performance.
    Weaknesses
    Earnings recorded a net miss of -5.7% measured by company count, while nonfinancial revenue missed by -14.8% on the same basis; consumer staples were weak.
    Comparison
    Performance improved slightly from 1Q26, but earnings surprise breadth was weaker than MSCI China's.
    Risks
    The earnings season remains at an early stage, with the earnings sample covering only 32% of the index weight and the revenue sample only 23%.

Key data

  • MSCI China earnings sample140 companiesAs of August 21, 2026, 191/576 constituents had reported; the analytical sample represented 24% of the company count and 42% of the index weight.
  • MSCI China net earnings beat+4.3%Measured by company count; the figure was -8.7% in 1Q26.
  • MSCI China market-cap-weighted earnings beat+3.7%The figure was -3.0% in 1Q26.
  • MSCI China health care earnings+29.4% / +15.5%Net beat measured by company count and market-cap-weighted beat, respectively, with 48% of sector market capitalization reported.
  • MSCI China information technology earnings+9.4% / +8.5%Net beat measured by company count and market-cap-weighted beat, respectively, with 38% of sector market capitalization reported.
  • MSCI China nonfinancial revenue sample121 companies175/576 companies had reported; the sample represented 25% of the company count and 37% of the index weight.
  • MSCI China nonfinancial revenue surprise-9.9% / 0.0%Net surprise measured by company count and market-cap-weighted surprise, respectively.
  • A-share earnings sample106 companies172 companies had reported; the sample represented 19% of the MSCI China A Onshore Index's company count and 32% of its weight.
  • A-share net earnings beat-5.7%Measured by company count; the figure was -12.5% in 1Q26.
  • A-share market-cap-weighted earnings beat+2.7%The figure was +0.3% in 1Q26.
  • A-share nonfinancial revenue sample81 companies171 companies had reported; the sample represented 16% of the index's company count and 23% of its weight.
  • A-share nonfinancial revenue surprise-14.8% / -0.4%Company-count and market-cap-weighted measures, respectively; the magnitude of the company-count miss improved slightly from 1Q26.

Impact & implications

The report shows that interim 2Q26 earnings for Chinese equities did not broadly and substantially miss expectations. Market-cap-weighted results for both MSCI China and A-shares were broadly in line with expectations and improved from 1Q26. However, A-share earnings breadth measured by company count remained weak, while revenue breadth lagged earnings in both markets, indicating that the current improvement is more concentrated among certain index heavyweights and in profits supported by cost control rather than broad-based revenue growth.

Risks

  • The current review covers only a portion of companies that have reported, and the improving MSCI China trend may not persist through the end of the 2Q26 earnings season.
  • The A-share earnings season remains at an early stage, and the current sample results may not represent the final performance of the overall A-share index.

What to watch

  • Monitor whether the earnings improvement in MSCI China and A-shares relative to 1Q26 can continue through the full 2Q26 earnings season.
  • Monitor the impact of rising artificial intelligence investment and weak consumption on internet companies and Chinese equity earnings in subsequent quarters.
Zhejiang ICP No. 2022035445-5
Disclaimer: Market data, charts, indicators, research views, and other information provided on this website are intended solely for information display, research communication, and educational reference. They should not be regarded as personalized investment advice, securities recommendations, trading instructions, solicitations, or guarantees of return. While we strive to improve the reliability of our data and content, such information may still be subject to delays, errors, incompleteness, or untimely updates due to source differences, methodological limitations, system processing, or market volatility. Users should exercise independent judgment based on their own circumstances and bear all risks and responsibilities arising from the use of this website.

Settings

Sign in to view recent logins